Add to Favourites
To login click here
Iktos, a Paris-based company specializing in AI for new drug discovery, has raised €15.5M in Series A funding. The round was led by M Ventures and Debiopharm Innovation Fund with participation from Omnes Capital. The funds will be used to expand Iktos’ AI technology platform, launch Iktos Robotics, and extend its solutions to biological products. The company develops a proprietary solution based on generative learning models to design molecules in silico to meet success criteria of a small molecule discovery project.